Previous Close | 40.01 |
Open | 40.23 |
Bid | 41.07 x 200 |
Ask | 41.26 x 100 |
Day's Range | 40.05 - 41.59 |
52 Week Range | 27.99 - 50.99 |
Volume | |
Avg. Volume | 363,458 |
Market Cap | 3.1B |
Beta (5Y Monthly) | 1.18 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Xenon Pharmaceuticals Inc (NASDAQ:XENE), a clinical-stage biopharmaceutical company, focuses on developing therapeutics to improve the lives of patients with neurological disorders.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript February 29, 2024 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.64, expectations were $-0.76. Xenon Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]